Amazon's takeover of One Medical, coupled with the surging popularity of GLP-1 receptor agonists, is shaping a new medical strategy. The combination of One Medical's general practitioner network with use to GLP-1 drugs signals a significant evolution in how health is managed. Observers suggest th